No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Humans
-
Indoles / therapeutic use*
-
Lymph Nodes / pathology*
-
Lymph Nodes / surgery
-
Lymphatic Metastasis
-
Magnetic Resonance Imaging
-
Male
-
Melanoma / drug therapy*
-
Melanoma / genetics
-
Melanoma / pathology
-
Melanoma / secondary
-
Melanoma / surgery*
-
Middle Aged
-
Multimodal Imaging
-
Mutation*
-
Neoadjuvant Therapy / methods*
-
Neoplasm Staging
-
Positron-Emission Tomography
-
Proto-Oncogene Proteins B-raf / drug effects
-
Proto-Oncogene Proteins B-raf / genetics*
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / genetics
-
Skin Neoplasms / pathology
-
Skin Neoplasms / surgery*
-
Sulfonamides / therapeutic use*
-
Tomography, X-Ray Computed
-
Treatment Outcome
-
Vemurafenib
Substances
-
Antineoplastic Agents
-
Indoles
-
Sulfonamides
-
Vemurafenib
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf